Mathias Hartwig Bjerager is a Senior Scientist specializing in Injectable Formulation Development at Novo Nordisk since 2024. Previously, they served as a Research Scientist at Novo Nordisk from 2022 to 2024, where they managed various aspects of pharmaceutical development, including drug stability and regulatory submissions. Mathias gained valuable experience as an intern at F-star Biotechnology Ltd. from 2015 to 2016, focusing on phage display and protein engineering. They hold a Master of Science in Biotechnology and a Bachelor's Degree in Biotechnology from Aarhus University, along with a Gymnasieeksamen in a scientific study program from Ikast Highschool.
This person is not in the org chart
This person is not in any teams
This person is not in any offices